Pacira BioSciences, Inc.
Pacira BioSciences, Inc.（PCRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PCRX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
15
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Pacira BioSciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
PCRX 季度内部人买卖趋势
PCRX 内幕交易卖出 · PCRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · PCRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PCRX 高管卖出股份 · PCRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 3, 2026 | RIKER LAUREN Senior Vice President, Finance | Other | 3,187 | $71K | Form 4 |
| Jun 3, 2026 | SLONIN JONATHAN Chief Medical Officer | Other | 4,728 | $106K | Form 4 |
| Jun 3, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Other | 8,528 | $190K | Form 4 |
| Jun 4, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Sale | 10,259 | $228K | Form 4 |
| Apr 23, 2026 | Cross Shawn CFO | Option | 12,941 | $213K | Form 4 |
| Apr 23, 2026 | Cross Shawn CFO | Sale | 12,941 | $326K | Form 4 |
| Apr 20, 2026 | Cross Shawn CFO | Option | 7,714 | $127K | Form 4 |
| Apr 21, 2026 | Cross Shawn CFO | Option | 2,845 | $47K | Form 4 |
| Apr 22, 2026 | Cross Shawn CFO | Option | 1,500 | $25K | Form 4 |
| Apr 20, 2026 | Cross Shawn CFO | Sale | 7,714 | $194K | Form 4 |
| Apr 22, 2026 | Cross Shawn CFO | Sale | 1,500 | $38K | Form 4 |
| Mar 17, 2026 | SLONIN JONATHAN Chief Medical Officer | Sale | 3,261 | $74K | Form 4 |
| Mar 17, 2026 | Froimson Mark Director | Sale | 500 | $11K | Form 4 |
| Feb 11, 2026 | Cross Shawn CFO | Award | 49,091 | — | Form 4 |
| Feb 11, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Award | 54,546 | — | Form 4 |
| Feb 11, 2026 | Teehan Brendan Chief Commercial Officer | Award | 51,714 | — | Form 4 |
| Feb 11, 2026 | RIKER LAUREN Senior Vice President, Finance | Award | 19,273 | — | Form 4 |
| Feb 11, 2026 | SLONIN JONATHAN Chief Medical Officer | Award | 54,546 | — | Form 4 |
| Feb 11, 2026 | Lee Frank D. CEO · Director | Award | 261,818 | — | Form 4 |
| Jan 30, 2026 | RIKER LAUREN Senior Vice President, Finance | Other | 2,751 | $57K | Form 4 |
| Feb 2, 2026 | RIKER LAUREN Senior Vice President, Finance | Sale | 4,000 | $83K | Form 4 |
| Jan 30, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Other | 17,134 | $352K | Form 4 |
| Feb 2, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Sale | 13,137 | $270K | Form 4 |
| Jan 30, 2026 | SLONIN JONATHAN Chief Medical Officer | Other | 6,168 | $127K | Form 4 |
| Jan 30, 2026 | Teehan Brendan Chief Commercial Officer | Other | 5,182 | $106K | Form 4 |
WILLIAMS KRISTEN
Chief Administrative Officer
日期
Jun 3
股数
8,528
均价
$22.32
总金额
$190K
WILLIAMS KRISTEN
Chief Administrative Officer
日期
Jun 4
股数
10,259
均价
$22.27
总金额
$228K
WILLIAMS KRISTEN
Chief Administrative Officer
日期
Jan 30
股数
17,134
均价
$20.54
总金额
$352K
WILLIAMS KRISTEN
Chief Administrative Officer
日期
Feb 2
股数
13,137
均价
$20.53
总金额
$270K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PCRX 内幕交易
PCRX 内幕交易
Pacira BioSciences, Inc.（PCRX）内幕交易数据来源于公司内部人（包括Cross Shawn (CFO), SLONIN JONATHAN (Chief Medical Officer), RIKER LAUREN (Senior Vice President, Finance)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PCRX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Pacira BioSciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PCRX 内幕交易 · 5个问题Pacira BioSciences, Inc.（PCRX）的内部人包括高管和董事，如Cross Shawn (CFO), SLONIN JONATHAN (Chief Medical Officer), RIKER LAUREN (Senior Vice President, Finance)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026